BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lori A, Schultebraucks K, Galatzer-Levy I, Daskalakis NP, Katrinli S, Smith AK, Myers AJ, Richholt R, Huentelman M, Guffanti G, Wuchty S, Gould F, Harvey PD, Nemeroff CB, Jovanovic T, Gerasimov ES, Maples-Keller JL, Stevens JS, Michopoulos V, Rothbaum BO, Wingo AP, Ressler KJ. Transcriptome-wide association study of post-trauma symptom trajectories identified GRIN3B as a potential biomarker for PTSD development. Neuropsychopharmacology 2021;46:1811-20. [PMID: 34188182 DOI: 10.1038/s41386-021-01073-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Schultebraucks K, Stevens JS, Michopoulos V, Maples-Keller J, Lyu J, Smith RN, Rothbaum BO, Ressler KJ, Galatzer-Levy IR, Powers A. Development and validation of a brief screener for posttraumatic stress disorder risk in emergency medical settings. Gen Hosp Psychiatry 2023;81:46-50. [PMID: 36764261 DOI: 10.1016/j.genhosppsych.2023.01.012] [Reference Citation Analysis]
2 Fessel J. Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD). J Clin Med 2023;12. [PMID: 36836215 DOI: 10.3390/jcm12041680] [Reference Citation Analysis]
3 Tyler RE, Besheer J, Joffe ME. Advances in translating mGlu2 and mGlu3 receptor selective allosteric modulators as breakthrough treatments for affective disorders and alcohol use disorder. Pharmacol Biochem Behav 2022;219:173450. [PMID: 35988792 DOI: 10.1016/j.pbb.2022.173450] [Reference Citation Analysis]
4 Sterina E, Michopoulos V, Linnstaedt SD, Neylan TC, Clifford GD, Ethun KF, Lori A, Wingo AP, Rothbaum BO, Ressler KJ, Stevens JS. Time of trauma prospectively affects PTSD symptom severity: The impact of circadian rhythms and cortisol. Psychoneuroendocrinology 2022;141:105729. [PMID: 35413575 DOI: 10.1016/j.psyneuen.2022.105729] [Reference Citation Analysis]
5 Ressler KJ, Berretta S, Bolshakov VY, Rosso IM, Meloni EG, Rauch SL, Carlezon WA. Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits. Nat Rev Neurol. [DOI: 10.1038/s41582-022-00635-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
6 Dunsmoor JE, Cisler JM, Fonzo GA, Creech SK, Nemeroff CB. Laboratory models of post-traumatic stress disorder: The elusive bridge to translation. Neuron 2022:S0896-6273(22)00202-1. [PMID: 35325617 DOI: 10.1016/j.neuron.2022.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
7 Tyler RE, Bluitt MN, Engers JL, Lindsley CW, Besheer J. The effects of predator odor (TMT) exposure and mGlu3 NAM pretreatment on behavioral and NMDA receptor adaptations in the brain. Neuropharmacology 2022;207:108943. [PMID: 35007623 DOI: 10.1016/j.neuropharm.2022.108943] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Bryant RA. Controversies in Posttraumatic Stress Disorder. Toward a Science of Clinical Psychology 2022. [DOI: 10.1007/978-3-031-14332-8_18] [Reference Citation Analysis]